2m 2m 2m 2m 2m 2m 2m
HLTHCR TRIANGLE (HCTI)
NASDAQ
$2.39-$0.10 (-4.18%)
Price as of Jun 03, 2026 7:45 PM EDT- $5.2MMarket Cap
- -97.75%1-Year Change
- Health Information ServicesIndustry
HLTHCR TRIANGLE (HCTI)
$2.39-$0.10 (-4.18%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 13.9M +18.77% | 11.7M -64.77% | 33.2M -27.64% | 45.9M +30.10% | |
Cost of Revenue | 12.0M +36.28% | 8.8M -66.68% | 26.4M -23.60% | 34.6M +39.77% | |
Gross Profit | 1.2B +15.42% | 1.1B 0.00% | 1.1B +9,373.22% | 11.3M +7.35% | |
Sales and Marketing Expense | 3.1M +39.99% | 2.2M -52.83% | 4.7M -31.40% | 6.8M +43.00% | |
Research and Development Expense | -536,000 +24.94% | -429,000 -46.31% | -799,000 -86.58% | -6.0M +13.23% | |
Depreciation and Amortization Expense | 705,000 -20.70% | 889,000 -43.23% | 1.6M -53.59% | 3.4M +137.34% | |
Total Operating Expenses | 11.7M +52.85% | 7.6M -47.20% | 14.5M -33.34% | 21.7M +388.94% | |
Operating Profit | -9.8M +106.04% | -4.8M -38.26% | -7.7M -26.12% | -10.4M +94.36% | |
Interest Income | N/A N/A | N/A N/A | 12,000 -98.90% | 1.1M N/A | |
Interest Expense | -567,000 -53.26% | -1.2M +25.31% | -968,000 +356.60% | -212,000 -62.59% | |
Interest Income and Expense and Net | -567,000 -53.26% | -1.2M +26.88% | -956,000 -209.26% | 875,000 +254.39% | |
Total Nonoperating Income and Expense | -567,000 -53.26% | -1.2M +25.31% | -968,000 +356.60% | -212,000 -62.59% | |
Income before Taxes | -9.5M +59.07% | -6.0M -31.14% | -8.7M -9.39% | -9.5M +61.11% | |
Income Taxes | 0 -100.00% | 12,000 -65.71% | 35,000 -44.44% | 63,000 +159.84% | |
Extraordinary Items | N/A N/A | N/A N/A | 1.7M N/A | N/A N/A | |
Net Income | -9.5M +58.75% | -6.0M -31.28% | -8.7M -9.61% | -9.6M +61.51% | |
Net Income from Continuing Operations Applicable to Common | -9.5M +59.07% | -6.0M -31.42% | -8.7M -9.02% | -9.5M +61.11% | |
Basic EPS and Net Income | -152.30 +13,377.88% | -1.13 -45.67% | -2.08 N/A | N/A N/A | |
Diluted EPS and Net Income | -152.30 +13,377.88% | -1.13 -45.67% | -2.08 N/A | N/A N/A | |
Basic Weighted Average Shares | 61,873 -98.83% | 5.3M +26.30% | 4.2M N/A | N/A N/A | |
Diluted Weighted Average Shares | 61,873 -98.83% | 5.3M +26.30% | 4.2M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 7.6M +38,025.00% | 20,000 -98.38% | 1.2M -7.98% | 1.3M -24.22% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 7.6M +38,025.00% | 20,000 -98.38% | 1.2M -7.98% | 1.3M -24.22% | |
Total Current Assets | 13.2M +805.72% | 1.5M -74.31% | 5.7M -27.05% | 7.7M -34.35% | |
Accumulated Depreciation | 62,000 -48.33% | 120,000 +36.36% | 88,000 +125.64% | 39,000 +531.07% | |
Property and Plant and Equipment and Net | 5,000 -58.33% | 12,000 -72.73% | 44,000 -45.00% | 80,000 +7.74% | |
Total Long-Term Assets | 5,000 -58.33% | 12,000 -72.73% | 44,000 -45.00% | 80,000 +7.74% | |
Total Assets | 22.7M +1,059.41% | 2.0M -71.41% | 6.9M -66.97% | 20.8M -15.64% | |
Income Taxes Payable | N/A N/A | N/A N/A | 217,000 N/A | N/A N/A | |
Total Short-Term Debt | 10.7M +305.17% | 2.6M -30.04% | 3.8M +57.05% | 2.4M +9.20% | |
Total Current Liabilities | 12.8M +80.81% | 7.1M -7.54% | 7.7M +24.46% | 6.1M -1.65% | |
Total Long-Term Debt | 1.0B -59.65% | 2.5B +2,581,792.78% | 97,000 -97.71% | 4.2M -0.02% | |
Total Long-Term Liabilities | 13.5M -95.13% | 277.0M +285,467.01% | 97,000 +76.36% | 55,000 -68.78% | |
Total Liabilities | 12.8M +80.81% | 7.1M -14.23% | 8.2M -1.50% | 8.4M -1.21% | |
Retained Earnings | -43.0M +28.08% | -33.6M +21.63% | -27.6M +119.62% | -12.6M +371.78% | |
Total Stockholders Equity | 9.9M +294.45% | -5.1M +267.65% | -1.4M -111.15% | 12.5M -22.66% | |
Total Shares Outstanding | 451,437 -92.03% | 5.7M +31.52% | 4.3M -89.67% | 41.7M +18.29% | |
Cash Flow | |||||
Cash from Operating Activities | -16.5M +1,428.49% | -1.1M -49.74% | -2.2M -17.27% | -2.6M -64.35% | |
Capital Expenditures | 6,000 N/A | N/A N/A | 12,000 N/A | N/A N/A | |
Cash from Investing Activities | -1.8M N/A | N/A N/A | -12,000 -99.64% | -3.3M -56.49% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 25.9M +19,557.89% | -133,000 -106.47% | 2.1M -62.55% | 5.5M -64.09% | |
Financials Ratio | |||||
Gross Margin | 13.61% -44.94% | 24.71% +21.06% | 20.41% -17.08% | 24.62% N/A | |
Operating Margin | -70.47% +73.48% | -40.62% +75.27% | -23.18% +2.10% | -22.70% N/A | |
Return on Assets | -76.74% -43.31% | -135.37% +115.23% | -62.89% +48.48% | -42.36% N/A | |
Return on Equity | -392.38% -313.81% | 183.52% +217.12% | -156.69% +133.26% | -67.17% N/A | |
Revenue Growth | 18.77% +128.97% | -64.77% +134.35% | -27.64% -191.83% | 30.10% N/A | |
Current Ratio | 1.03 +401.02% | 0.21 -72.23% | 0.74 -41.38% | 1.26 N/A | |
Cash Ratio | 0.60 +21,189.29% | 0.003 -98.26% | 0.16 -26.04% | 0.22 N/A | |
Debt-to-Equity Ratio | 102.70 +120.95% | -490.24 +17,452.44% | -2.79 -623.62% | 0.53 N/A | |
Debt-to-Assets Ratio | 44.92 -96.49% | 1,278.47 +225,579.29% | 0.57 +76.70% | 0.32 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow